Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Dr. Martens's Enterprise Value is $1,162 Mil.
Dr. Martens's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $79 Mil. Therefore, Dr. Martens's EV-to-EBIT ratio for today is 14.69.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Dr. Martens's Enterprise Value is $1,162 Mil.
Dr. Martens's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $171 Mil. Therefore, Dr. Martens's EV-to-EBITDA ratio for today is 6.80.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Dr. Martens's Enterprise Value is $1,162 Mil.
Dr. Martens's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $1,026 Mil. Therefore, Dr. Martens's EV-to-Revenue ratio for today is 1.13.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Dr. Martens's Enterprise Value is $1,162 Mil.
Dr. Martens's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $174 Mil. Therefore, Dr. Martens's EV-to-FCF ratio for today is 6.67.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Dr. Martens (OTCPK:DRMTY) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Dr. Martens's current Enterprise Value is $1,162 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Dr. Martens's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $79 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Dr. Martens's current Enterprise Value is $1,162 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Dr. Martens's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $171 Mil.
Dr. Martens's current Enterprise Value is $1,162 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Dr. Martens's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $1,026 Mil.
Dr. Martens's current Enterprise Value is $1,162 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Dr. Martens's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $190 Mil.
Dr. Martens's current Enterprise Value is $1,162 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Dr. Martens's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $174 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr. Martens Enterprise Value Related Terms
Dr. Martens Enterprise Value Historical Data
* Premium members only.
The historical data trend for Dr. Martens's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DRMTY vs NKE, DECK, ONON: Enterprise Value Comparison
For the Footwear & Accessories subindustry, Dr. Martens's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Martens Enterprise Value vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Dr. Martens's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Dr. Martens's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Dr. Martens's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr. Martens (DRMTY) has a Enterprise Value of $1,162 Mil as of Jun. 25, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Dr. Martens and its competitors.
Is Dr. Martens' Enterprise Value too high?
Dr. Martens' current Enterprise Value is $1,162 Mil. Overall, Dr. Martens has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' Enterprise Value compare to NKE and DECK?
Dr. Martens' Enterprise Value of $1,162 Mil can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Manufacturing - Apparel & Accessories company?
A good Enterprise Value depends on the Manufacturing - Apparel & Accessories industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Dr. Martens and its competitors. Dr. Martens's current Enterprise Value is $1,162 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (DRMTY) is currently considered Fairly Valued. The stock's GF Value™ is $1.89, compared to a current price of $1.83 — trading 3.2% below its estimated fair value. The current Enterprise Value is $1,162 Mil. Dr. Martens' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Dr. Martens (DRMTY), the current Enterprise Value is $1,162 Mil as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr. Martens (DRMTY) Overvalued in 2026?
Based on GuruFocus' analysis, Dr. Martens stock appears to be undervalued.
The current stock price of $1.83 is trading 3.2% below its estimated GF Value™ of $1.89.
GuruFocus considers Dr. Martens to be Fairly Valued.
Key valuation signals for DRMTY:
Enterprise Value: $1,162 Mil
GF Value™: $1.89 vs. price of $1.83 (3.2% below fair value)
No single metric tells the full story. See the DRMTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
73GF Score
Get the complete analysis for DRMTY
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DRMTY has been successfully added to your 
